Protara Therapeutics, Inc.
Biotechnology company · New York, United States · Nasdaq: TARA
Protara Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker TARA. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2017.
Protara Therapeutics at a glance
What does Protara Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $22 million sold (2017).
Frequently asked questions about Protara Therapeutics
Where is Protara Therapeutics headquartered?
Protara Therapeutics, Inc. is headquartered in New York, United States.
What does Protara Therapeutics do?
Protara Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Protara Therapeutics a public company?
Yes. Protara Therapeutics, Inc. trades on Nasdaq under the ticker TARA.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.